" 99.1 
scope. 
(a) this part applies to the dissemination of information on human drugs, including biologics, and devices where the information to be disseminated: 
(1) concerns the safety, effectiveness, or benefit of a use that is not included in the approved labeling for a drug or device approved by the food and drug administration for marketing or in the statement of intended use for a device cleared by the food and drug administration for marketing; and 
(2) will be disseminated to a health care practitioner, pharmacy benefit manager, health insurance issuer, group health plan, or federal or state government agency. 
(b) this part does not apply to a manufacturer's dissemination of information that responds to a health care practitioner's unsolicited request.", 
